I Peace debuts a novel approach to longevity care with personalized iPS cell production and rejuvenation therapies in the U.S. By reprogramming cells to a youthful state, CEO Koji Tanabe introduces a scalable, cost-effective method that may reshape regenerative medicine. The Manila Times details this innovation, highlighting its potential impact on healthy aging.